These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 587022)

  • 1. [Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].
    Oksenhendler G; Leroy A; Humbert G; Fillastre JP; Winckler C
    Anesth Analg (Paris); 1977; 34(1):93-110. PubMed ID: 587022
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A; Oksenhendler G; Fillastre JP; Humbert G
    J Urol Nephrol (Paris); 1977 Sep; 83(9):738-41. PubMed ID: 243544
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients.
    Leroy A; Humbert G; Oksenhendler G; Fillastre JP
    J Antimicrob Chemother; 1976 Dec; 2(4):373-81. PubMed ID: 1052072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of inactivation of aminosides. Relationship to phenotype in Gram negative bacilli].
    Witchitz JL
    Nouv Presse Med; 1975 Sep; 4(30):2187-90. PubMed ID: 52143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of amikacin in subjects with normal renal function, in chronic renal failure and during hemodialysis].
    Oksenhendler G; Leroy A; Fillastre JP; Humbert G
    Nouv Presse Med; 1979 Oct; 8(42):3426-9. PubMed ID: 537888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic basis for using tobramycin and sisomicin in treating pyelonephritis of the transplanted kidney].
    Navashin SM; Treskina OS; Firsov AA; Bogomolova NS; Belorusov OS
    Antibiotiki; 1983 Jul; 28(7):539-45. PubMed ID: 6354075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and clinical observations of sisomicin, a newly developed aminoglycoside derivative (author's transl)].
    Lode H; Kemmerich B; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1975 Oct; 100(42):2144-50. PubMed ID: 1164890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal accumulation of amikacin, tobramycin and gentamycin in the rat.
    Nieminen L; Kasanen A; Kangas L; Sairio E; Anttila M
    Experientia; 1978 Oct; 34(10):1335-6. PubMed ID: 738411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amikacin, netilmicin and tobramycin in children with chronic renal failure.
    Nayir A; Sirin A; Emre S; Eti S; Yeşilbek T
    Turk J Pediatr; 1995; 37(2):111-6. PubMed ID: 7597761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amikacin and tobramycin].
    Bergan T; Melby K
    Tidsskr Nor Laegeforen; 1978 Apr; 98(12):639-41. PubMed ID: 653664
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measuring the excretion of aminoglycosides into the saliva].
    Kelentey BA; Kelentey BJ
    Fogorv Sz; 1991 Oct; 84(10):313-7. PubMed ID: 1765204
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].
    Naumann P; Rosin H
    Adv Clin Pharmacol; 1978; 15():23-34. PubMed ID: 676876
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin.
    Lode H; Kemmerich B; Koeppe P
    Antimicrob Agents Chemother; 1975 Oct; 8(4):396-401. PubMed ID: 1103722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig.
    Brummett RE; Fox KE
    Proc West Pharmacol Soc; 1977; 20():449-53. PubMed ID: 896854
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion.
    Mombelli G; Coppens L; Thys JP; Klastersky J
    Antimicrob Agents Chemother; 1981 Jan; 19(1):72-5. PubMed ID: 7247362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.